A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer

Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck

NCT04397341 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT03818542 ·Status: TERMINATED ·Phase: PHASE1

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

NCT01312350 ·Status: COMPLETED ·Phase: PHASE2

Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

NCT07065630 ·Status: RECRUITING ·Phase: PHASE2

Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer

NCT00875849 ·Status: COMPLETED ·Phase: PHASE2

Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

NCT00868491 ·Status: COMPLETED ·Phase: PHASE2

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

NCT05749042 ·Status: UNKNOWN ·Phase: PHASE2

Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT01086826 ·Status: COMPLETED ·Phase: PHASE3

Expansion Trial for Axitinib In Head And Neck Cancer

NCT02762513 ·Status: COMPLETED ·Phase: PHASE2

A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

NCT01046266 ·Status: COMPLETED ·Phase: PHASE1

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

NCT00033618 ·Status: COMPLETED ·Phase: PHASE2

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

NCT00400205 ·Status: TERMINATED ·Phase: PHASE2

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

NCT00272181 ·Status: TERMINATED ·Phase: PHASE2

Randomized Amifostine For SCCHN

NCT00095927 ·Status: COMPLETED ·Phase: PHASE2

Study of Chemo-Immunotherapy in Head and Neck Cancer Patients

NCT01149902 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer

NCT00131638 ·Status: COMPLETED ·Phase: PHASE3

A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck

NCT04830592 ·Status: COMPLETED ·Phase: PHASE1

Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer

NCT02079324 ·Status: COMPLETED ·Phase: PHASE1

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627 ·Status: COMPLETED ·Phase: PHASE2

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

NCT02360501 ·Status: COMPLETED ·Phase: PHASE2

CD40 Agonist and PD-1 Inhibitor in HNSCC

NCT06159621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer

NCT00014118 ·Status: COMPLETED ·Phase: PHASE2

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

NCT02075112 ·Status: COMPLETED ·Phase: PHASE1

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

NCT04367909 ·Status: UNKNOWN ·Phase: PHASE2

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

NCT00412776 ·Status: TERMINATED ·Phase: PHASE2/PHASE3